Daclatasvir plus sofosbuvir with or without ribavirin for treatment of chronic HCV infection in patients with advanced liver disease: Results of a european compassionate use program

Authors
Category Primary study
JournalJournal of Hepatology
Year 2016
This article has no abstract
Epistemonikos ID: ca943aae1bed5e7efb50a6ed2e736e5ffbcee951
First added on: Feb 07, 2025